From: Statin prescription among patients with type 2 diabetes in Botswana: findings and implications
Characteristics | Statin not prescribed (n = 260) | Statin prescribed (n = 217) | P-value |
---|---|---|---|
Sex | |||
 Males, n (%) | 92(35.4) | 68(31.3) | 0.351 |
 Female, n (%) | 168(64.6) | 149(68.7) | |
Diabetes duration, median, IQR, years | 6(2–12) | 8.9(4–15) | < 0.001 |
 Duration ≤10 years | 179(68.9) | 134(61.8) | 0.104 |
 Diabetes duration > 10 years | 81(31.1) | 83(38.2) | |
Age, mean (SD), years | 59.2(10.8) | 61.5(10.7) | 0.018 |
 Age ≤ 40 years, n (%) | 12(4.6) | 4(1.8) | < 0.094 |
 Age > 40 years n (%) | 248(95.4) | 213(98.2) | |
Marital status | |||
 Living alone n (%) | 135(51.9) | 112(51.6) | 0.946 |
 Living with a partner n (%) | 125(48.1) | 105 (48.4) | |
Education status | |||
  ≤ Primary education, n (%) | 166(63.9) | 140(64.2) | 0.879 |
  ≥ Secondary or tertiary, n (%) | 94(36.1) | 77(35.8) | |
Hypertension n (%) | 212(81.5) | 192 (88.5) | 0.036 |
Antihypertensive use n (%) | 203(78.1) | 186(85.7) | 0.032 |
Smoking | 13(5.0) | 3(1.4) | 0.029 |
CVD, n (%) | 20(7.7) | 22(10.1) | 0.538 |
 PAD, n (%) | 7(2.7) | 4(1.8) | 0.625 |
 Coronary artery disease n (%) | 6(2.3) | 6(2.8) | 0.751 |
 Cerebrovascular diseases n (%) | 9(3.5) | 13(6.0) | 0.190 |
BMI, mean (SD) kg/m2 | 30.3(5.7) | 31.2(6.2) | 0.113 |
 Normal weight n (%) | 50(19.2) | 35(16.1) | 0.669 |
 Overweight n (%) | 79(30.4) | 67(30.9) | |
 Obese n (%) | 135(47.9) | 115(52.8) | |
WHR, mean (SD) | 0.94(0.08) | 0.95(0.10) | 0.106 |
 Low WHR n (%) | 46(17.7) | 33(15.2) | 0.467 |
 High WHR n (%) | 214(82.3) | 184(84.8) | |
CKD, n (%) | 20(7.7) | 34 (15.7) | 0.006 |
Proteinuria, n (%) | 30 (11.5) | 21(9.7) | 0.512 |
HbA1c mean (SD), % | 8.4(2.6) | 8.4(2.2) | 0.948 |
Baseline LDL-C mean (SD), mmol/L | 2.9(0.9) | 3.3(1.4) | 0.003 |
 Normal | 177(68.1) | 120(55.3) | < 0.001 |
 High | 17(6.5) | 42(19.4) | |
 Missing | 66(25.4) | 55(25.3) |  |